GeneDx (WGS) announced Mimi Lee as chief precision medicine officer. As chief precision medicine officer, Lee will lead GeneDx’s work to empower customizable precision medicine as the standard of care, leveraging the power of genomics to predict, prevent, and optimize health outcomes throughout a person’s lifetime. Lee joins GeneDx from the Advanced Research Projects Agency for Health, where she designed and directed public-private programs.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGS:
- GeneDx selected by Florida State University as partner for Sunshine Genetics Act
- DASH, DE, BABA: Cathie Wood Loads Up on DoorDash, Deere & Alibaba, Trims Stakes in ADPT and Others
- GeneDx appoints Gurry as Chief Business Officer
- Eli Lilly’s (LLY) AI Chief Joins the Board of GeneDx
- GeneDx Holdings Appoints Thomas Fuchs to Board